{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T05:09:13Z","timestamp":1759813753043},"reference-count":40,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2014,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Hematotoxicity in individuals genetically deficient in glucose-6-phosphate dehydrogenase (G6PD) activity is the major limitation of primaquine (PQ), the only antimalarial drug in clinical use for treatment of relapsing\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Plasmodium vivax<\/jats:named-content>\n            malaria. PQ is currently clinically used in its racemic form. A scalable procedure was developed to resolve racemic PQ, thus providing pure enantiomers for the first time for detailed preclinical evaluation and potentially for clinical use. These enantiomers were compared for antiparasitic activity using several mouse models and also for general and hematological toxicities in mice and dogs. (+)-(\n            <jats:italic>S<\/jats:italic>\n            )-PQ showed better suppressive and causal prophylactic activity than (\u2212)-(\n            <jats:italic>R<\/jats:italic>\n            )-PQ in mice infected with\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Plasmodium berghei<\/jats:named-content>\n            . Similarly, (+)-(\n            <jats:italic>S<\/jats:italic>\n            )-PQ was a more potent suppressive agent than (\u2212)-(\n            <jats:italic>R<\/jats:italic>\n            )-PQ in a mouse model of\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Pneumocystis carinii<\/jats:named-content>\n            pneumonia. However, at higher doses, (+)-(\n            <jats:italic>S<\/jats:italic>\n            )-PQ also showed more systemic toxicity for mice. In beagle dogs, (+)-(\n            <jats:italic>S<\/jats:italic>\n            )-PQ caused more methemoglobinemia and was toxic at 5 mg\/kg of body weight\/day given orally for 3 days, while (\u2212)-(\n            <jats:italic>R<\/jats:italic>\n            )-PQ was well tolerated. In a novel mouse model of hemolytic anemia associated with human G6PD deficiency, it was also demonstrated that (\u2212)-(\n            <jats:italic>R<\/jats:italic>\n            )-PQ was less hemolytic than (+)-(\n            <jats:italic>S<\/jats:italic>\n            )-PQ for the G6PD-deficient human red cells engrafted in the NOD-SCID mice. All these data suggest that while (+)-(\n            <jats:italic>S<\/jats:italic>\n            )-PQ shows greater potency in terms of antiparasitic efficacy in rodents, it is also more hematotoxic than (\u2212)-(\n            <jats:italic>R<\/jats:italic>\n            )-PQ in mice and dogs. Activity and toxicity differences of PQ enantiomers in different species can be attributed to their different pharmacokinetic and metabolic profiles. Taken together, these studies suggest that (\u2212)-(\n            <jats:italic>R<\/jats:italic>\n            )-PQ may have a better safety margin than the racemate in human.\n          <\/jats:p>","DOI":"10.1128\/aac.02674-13","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T07:42:17Z","timestamp":1402386137000},"page":"4737-4744","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":17,"title":["Scalable Preparation and Differential Pharmacologic and Toxicologic Profiles of Primaquine Enantiomers"],"prefix":"10.1128","volume":"58","author":[{"given":"N. P. Dhammika","family":"Nanayakkara","sequence":"first","affiliation":[{"name":"National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, Mississippi, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babu L.","family":"Tekwani","sequence":"additional","affiliation":[{"name":"National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, Mississippi, USA"},{"name":"Department of Pharmacology, University of Mississippi, University, Mississippi, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. M. T. Bandara","family":"Herath","sequence":"additional","affiliation":[{"name":"National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, Mississippi, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajnish","family":"Sahu","sequence":"additional","affiliation":[{"name":"National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, Mississippi, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montip","family":"Gettayacamin","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, U.S. Army Medical Component, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anchalee","family":"Tungtaeng","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, U.S. Army Medical Component, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"van Gessel","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, U.S. Army Medical Component, Armed Forces Research Institute of Medical Sciences (AFRIMS), Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Baresel","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina S.","family":"Wickham","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn S.","family":"Bartlett","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank R.","family":"Fronczek","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Louisiana State University, Baton Rouge, Louisiana, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Melendez","sequence":"additional","affiliation":[{"name":"Department of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Ohrt","sequence":"additional","affiliation":[{"name":"Department of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Reichard","sequence":"additional","affiliation":[{"name":"Department of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"McChesney","sequence":"additional","affiliation":[{"name":"Ironstone Separations, Inc., Etta, Mississippi, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Rochford","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry A.","family":"Walker","sequence":"additional","affiliation":[{"name":"National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, University of Mississippi, University, Mississippi, USA"},{"name":"Department of Pharmacology, University of Mississippi, University, Mississippi, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e328010b848"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2008.08.011"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-351"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2006.75.402"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-9-199605010-00003"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.2307\/3282248"},{"key":"e_1_3_3_8_2","first-page":"299","article-title":"The experimental chemotherapy of leishmaniasis. VI","volume":"74","author":"Trotter ER","year":"1980","unstructured":"TrotterERPetersWRobinsonBL. 1980. The experimental chemotherapy of leishmaniasis. VI. The development of rodent models for cutaneous infection with L. major and L. mexicana amazonensis. Ann. Trop. Med. Parasitol. 74:299\u2013319.","journal-title":"The development of rodent models for cutaneous infection with L. major and L. mexicana amazonensis. Ann. Trop. Med. Parasitol."},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt196453307"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1962.03620140081013"},{"key":"e_1_3_3_11_2","first-page":"905","article-title":"The hemolytic effect of primaquine. XV","volume":"59","author":"Brewer GJ","year":"1962","unstructured":"BrewerGJTarlovARKellermeyerRWAlvingAS. 1962. The hemolytic effect of primaquine. XV. Role of methemoglobin. J. Lab. Clin. Med. 59:905\u2013917.","journal-title":"Role of methemoglobin. J. Lab. Clin. Med."},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00645-07"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00202a002"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.12.1.51"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(87)80072-8"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(88)90327-9"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(87)90312-1"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600770503"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.1557"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1550-7408.1997.tb05772.x"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1310402110"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342150-00004"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-259"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2009.07.012"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-12-212"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1984.tb02369.x"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600730418"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016363600790"},{"key":"e_1_3_3_29_2","first-page":"93","volume-title":"Primaquine: pharmacokinetics, metabolism, toxicity and activity","author":"Peters W","year":"1984","unstructured":"PetersWRobinsonBL. 1984. The activity of primaquine and its possible metabolites against rodent malaria, p 93\u2013101. In WernsdorferWHTriggPI (ed), Primaquine: pharmacokinetics, metabolism, toxicity and activity. John Wiley, Chichester, United Kingdom."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(85)90155-3"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)50504-X"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00402a001"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(88)90263-8"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/jms.3122"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1990.42.532"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00369a031"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.086488"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00220a025"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00219a003"},{"key":"e_1_3_3_40_2","first-page":"204","article-title":"Enantioselective pharmacokinetics of primaquine by healthy human volunteers","volume":"87","author":"Walker LA","year":"2012","unstructured":"WalkerLAAvulaBChaurasiyaNDSahuRHerathHMTBStanfordDSKhanSINanayakkaraNPDKhanIAMcChesneyJDYatesTWElsohlyMATekwaniBL. 2012. Enantioselective pharmacokinetics of primaquine by healthy human volunteers. Am. J. Trop. Med. Hyg. 87(Suppl 1):204.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001023"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02674-13","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02674-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:53:59Z","timestamp":1645484039000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02674-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["10.1128\/AAC.02674-13"],"URL":"https:\/\/doi.org\/10.1128\/aac.02674-13","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"2013-12-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-07-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}